A Delaware federal jury awarded $393 million to Edwards Lifesciences Corp. last month in a patent infringement case. The jury found that Medtronic Inc.’s CoreValve system had willfully infringed Edwards’ Cribier transcatheter heart valve patent. Edwards indicated that it would file a motion to seek a permanent injunction blocking the sale of the infringing products. That issue was not addressed in the jury’s verdict. But the attempts by Medtronic to invalidate the Edwards patents were rejected by the jury. Edwards was awarded $388.8 million for lost profits with an additional $4.8 million in royalties. This can be trebled due to the jury’s willfulness finding.
Edwards and Medtronic have been battling for a long time. This verdict is the latest development in the litigation involving the heart valve patent issue between the two companies. In 2010, a federal jury awarded $74 million to Edwards after Medtronic’s CoreValve unit was found to have infringed a separate heart valve patent known as the Andersen patent. Medtronic appealed to the Federal Circuit and lost, eventually paying more than $84 million to Edwards last year after interest had increased the original damages total.
A decision by Edwards on its request to enjoin Medtronic’s entrance into the U.S. market and additional damages is still pending. The company said that because some of the sales have been found to infringe both the Andersen and Cribier patents, a portion of the damages awarded in the Cribier case could be reduced.
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.